We consider that the hemodialyzed patients included in our study, especially those with diabetes, suffer from degenerative vascular conditions, and so, VEGFβ exhibits an inhibiting effect on vascular wall cell apoptosis. The gene discussed is VEGFB; the disease is diabetes mellitus.